We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Helios Technologies
HLIO
$2.68B
| $327K | ﹤0.01% |
6,858
| – | – |
|
1352
Symbotic
SYM
$5.42B
| $327K | ﹤0.01% |
9,300
-2,300
| -20% | -$93K |
|
|
VSXY
1353
Victoria's Secret
VSXY
$7.32B
| $326K | ﹤0.01% |
18,442
+900
| +5% | +$17.1K |
|
1354
Claros Mortgage Trust
CMTG
$269M
| $325K | ﹤0.01% |
40,500
+11,200
| +38% | +$95.1K |
|
|
LTC
1355
LTC Properties
LTC
$2.11B
| $325K | ﹤0.01% |
9,430
| – | – |
|
1356
Hexcel
HXL
$7.64B
| $323K | ﹤0.01% |
5,174
-12,000
| -70% | -$805K |
|
1357
Kennametal
KMT
$2.35B
| $322K | ﹤0.01% |
13,674
-1,100
| -7% | -$27K |
|
1358
Enterprise Financial Services Corp
EFSC
$2.42B
| $321K | ﹤0.01% |
7,837
| – | – |
|
1359
Sprout Social
SPT
$578M
| $321K | ﹤0.01% |
9,000
+500
| +6% | +$20.1K |
|
1360
Safety Insurance
SAFT
$1.52B
| $319K | ﹤0.01% |
4,258
-300
| -7% | -$23.5K |
|
1361
Surgery Partners
SGRY
$2.01B
| $319K | ﹤0.01% |
13,400
+2,100
| +19% | +$53.9K |
|
|
LSXMA
1362
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $319K | ﹤0.01% |
14,400
| – | – |
|
|
DAWN
1363
DELISTED
Day One Biopharmaceuticals
DAWN
| $318K | ﹤0.01% |
23,100
+5,700
| +33% | +$83.4K |
|
1364
Prothena Corp
PRTA
$472M
| $318K | ﹤0.01% |
15,400
+6,000
| +64% | +$130K |
|
1365
Leggett & Platt
LEG
$1.31B
| $317K | ﹤0.01% |
27,700
| – | – |
|
1366
Patrick Industries
PATK
$2.8B
| $316K | ﹤0.01% |
4,362
-1,200
| -22% | -$87.8K |
|
1367
Utz Brands
UTZ
$1.25B
| $314K | ﹤0.01% |
18,900
| – | – |
|
1368
Privia Health
PRVA
$2.79B
| $313K | ﹤0.01% |
18,000
+3,000
| +20% | +$53.1K |
|
1369
Ironwood Pharmaceuticals
IRWD
$679M
| $312K | ﹤0.01% |
47,855
| – | – |
|
1370
Magnite
MGNI
$3.54B
| $312K | ﹤0.01% |
23,500
| – | – |
|
1371
NeoGenomics
NEO
$2.11B
| $312K | ﹤0.01% |
22,500
+2,600
| +13% | +$36.9K |
|
1372
Renasant Corp
RNST
$3.99B
| $312K | ﹤0.01% |
10,223
| – | – |
|
1373
SolarEdge
SEDG
$1.95B
| $312K | ﹤0.01% |
12,358
+1,200
| +11% | +$62.4K |
|
1374
Victory Capital Holdings
VCTR
$7.11B
| $310K | ﹤0.01% |
+6,500
| New | +$318K |
|
|
IBTX
1375
DELISTED
Independent Bank Group, Inc.
IBTX
| $310K | ﹤0.01% |
6,800
-1,100
| -14% | -$46.9K |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.